A detailed history of Rakuten Securities, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rakuten Securities, Inc. holds 685 shares of BMY stock, worth $39,442. This represents 0.02% of its overall portfolio holdings.

Number of Shares
685
Previous 2,024 66.16%
Holding current value
$39,442
Previous $84.1 Million 57.84%
% of portfolio
0.02%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$39.66 - $51.75 $53,104 - $69,293
-1,339 Reduced 66.16%
685 $35.4 Million
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $1,851 - $2,437
-46 Reduced 2.22%
2,024 $84.1 Million
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $58,199 - $65,987
1,213 Added 141.54%
2,070 $112 Million
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $41,547 - $49,577
857 New
857 $44 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.